Zobrazeno 1 - 10
of 16
pro vyhledávání: '"D, M Herrington"'
Publikováno v:
Diabetic medicine : a journal of the British Diabetic Association. 29(6)
Although current American Heart Association guidelines address C-reactive protein concentration and cardiovascular disease risk, it remains unclear whether this paradigm is consistent across populations with differing disease burdens. Individuals wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::33a41a0da60c4188a4733a1723671167
https://pubmed.ncbi.nlm.nih.gov/22211818
https://pubmed.ncbi.nlm.nih.gov/22211818
Publikováno v:
Minerva cardioangiologica. 55(4)
Observational studies have documented an association between lower rates of cardiovascular disease and hormone therapy (HT). Meanwhile, randomized clinical trials have documented increased rates of myocardial infarction and stroke in women receiving
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::22d0bfdfbf07fcd186bc632f40b480c1
https://pubmed.ncbi.nlm.nih.gov/17653023
https://pubmed.ncbi.nlm.nih.gov/17653023
Publikováno v:
Minerva ginecologica. 56(1)
Smoking remains a major health problem especially among women and it influences estrogen metabolism and the risk for multiple estrogen sensitive outcomes. Many indirect effects of smoking exist through the ability of the by-products to modify a varie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f77ec8358e1b6ec18d5e623034cf4fe4
https://pubmed.ncbi.nlm.nih.gov/14973414
https://pubmed.ncbi.nlm.nih.gov/14973414
Autor:
A M, Sherman, S A, Shumaker, P, Sharp, D M, Reboussin, C, Kancler, M, Walkup, D M, Herrington
Publikováno v:
Minerva ginecologica. 55(6)
Previous clinical studies suggest hormone replacement therapy (HRT) alleviates menopausal symptoms and may improve health-related quality of life (HRQL). Most studies on HRT and HRQL were limited in duration (12 months or less) and scope (few and non
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::028a3180e0548fbd4c64687956c2d620
https://pubmed.ncbi.nlm.nih.gov/14676740
https://pubmed.ncbi.nlm.nih.gov/14676740
Autor:
K R, Daniel, D M, Herrington
Publikováno v:
Minerva ginecologica. 55(3)
Limited data exists to guide secondary prevention in postmenopausal women with coronary heart disease (CHD). Treatment with HMG-CoA reductase inhibitors (statins) is likely to be beneficial for these patients. Yet, clinical trial results are conflict
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::856b1b404510f45efc21e6cfdf8f7222
https://pubmed.ncbi.nlm.nih.gov/14581866
https://pubmed.ncbi.nlm.nih.gov/14581866
Autor:
D M, Herrington, T L, Bush
Publikováno v:
Journal of women's healthgender-based medicine. 10(3)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::92da012e088bb560111d29ac3f1db3cc
https://pubmed.ncbi.nlm.nih.gov/11389777
https://pubmed.ncbi.nlm.nih.gov/11389777
Autor:
D M, Herrington, D M, Reboussin, K P, Klein, P C, Sharp, S A, Shumaker, T E, Snyder, K R, Geisinger
Publikováno v:
Controlled clinical trials. 21(3)
The Estrogen Replacement and Atherosclerosis (ERA) trial is a three-arm, randomized, placebo-controlled, double-blind trial to evaluate the effects of estrogen replacement therapy (0.625 mg/day oral conjugated estrogen) with or without continuous low
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f8bf2585e065313cc45d3317ad1d1abe
https://pubmed.ncbi.nlm.nih.gov/10822123
https://pubmed.ncbi.nlm.nih.gov/10822123
Autor:
D M, Herrington
Publikováno v:
Annals of internal medicine. 131(6)
The Heart and Estrogen/progestin Replacement Study (HERS) found no overall effect of 4.1 years of therapy with estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. However, within the overall null effect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::000f72e34d10e019f4ac14839dc3e835
https://pubmed.ncbi.nlm.nih.gov/10498564
https://pubmed.ncbi.nlm.nih.gov/10498564
Publikováno v:
JAMA. 277(16)
To determine the proportion of volunteer women with established heart disease who have low-density lipoprotein cholesterol (LDL-C) levels at or below the National Cholesterol Education Program Adult Treatment Panel goals and to determine what factors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::dd4c045b12a1f2e26a5ad6e6d536c99d
https://pubmed.ncbi.nlm.nih.gov/9272889
https://pubmed.ncbi.nlm.nih.gov/9272889
Publikováno v:
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 15(1 Pt 1)
Tissue culture, animal model, and epidemiologic studies suggest that dehydroepiandrosterone may inhibit atherosclerosis through its potent antiproliferative effects. Because cardiac allograft vasculopathy is predominantly a proliferative abnormality
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2c5b42ed9bf146f864eb1512af676f29
https://pubmed.ncbi.nlm.nih.gov/8820087
https://pubmed.ncbi.nlm.nih.gov/8820087